Clinical Trials Browser

Phase 2/3 × INDUSTRY × isavuconazole × Clear all

NCT00413439 2023-05-10

Safety, Efficacy and Pharmacokinetics of an Antifungal in Patients Undergoing Chemotherapy

Phase 2/3 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute